Guideline: LPAD Guideline (Lithuania): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::Ietuvos pulmonologų ir alergologų draugija]]. | '''Sponsor, manager or home institution:''' [[dataOwner::Ietuvos pulmonologų ir alergologų draugija]]. | ||
'''Type of information:''' Epidemiology, diagnostics, treatments, palliative care, quality of life, follow up of lung cancers. [https://www.pulmoalerg.lt/wp-admin/admin-post.php?action=preview_document&post_id=2306 Click here to learn more]. | '''Type of information:''' [[availableVariable::cancer incidence|Epidemiology]], diagnostics, [[availableVariable::medical procedures|treatments]], palliative care, quality of life, follow up of lung cancers. [https://www.pulmoalerg.lt/wp-admin/admin-post.php?action=preview_document&post_id=2306 Click here to learn more]. | ||
'''Cancer areas of interest:''' [[hasCancerType::C30-C39: Lung/chest cancers]]. [https://www.pulmoalerg.lt/wp-admin/admin-post.php?action=preview_document&post_id=2306 Click here to learn more]. | '''Cancer areas of interest:''' [[hasCancerType::C30-C39: Lung/chest cancers]]. [https://www.pulmoalerg.lt/wp-admin/admin-post.php?action=preview_document&post_id=2306 Click here to learn more]. | ||
'''Access to information:''' [https://www.pulmoalerg.lt/wp-admin/admin-post.php?action=preview_document&post_id=2306 Click here to access]. | '''Access to information:''' [https://www.pulmoalerg.lt/wp-admin/admin-post.php?action=preview_document&post_id=2306 Click here to access]. | ||
Revision as of 18:14, 10 June 2024
Go back to Lithuania page
Primary purpose: To guide health care professionals in diagnosing and treating lung cancer, considering the patient's individual needs, preferences, values, and characteristics.
Sponsor, manager or home institution: Ietuvos pulmonologų ir alergologų draugija.
Type of information: Epidemiology, diagnostics, treatments, palliative care, quality of life, follow up of lung cancers. Click here to learn more.
Cancer areas of interest: C30-C39: Lung/chest cancers. Click here to learn more.
Access to information: Click here to access.
